Stephen Paul Cobbold

Title: The Innovations of Stephen Paul Cobbold

Introduction

Stephen Paul Cobbold is a notable inventor based in Oxford, GB. He has made significant contributions to the field of biotechnology, particularly in the development of altered antibodies. With a total of 2 patents to his name, Cobbold's work has implications for therapeutic applications in medicine.

Latest Patents

Cobbold's latest patents focus on the creation of altered antibodies and their preparation. In these patents, an altered antibody chain is produced where the complementarity-determining regions (CDRs) of the variable domain are derived from a first mammalian species. The framework-encoding regions of DNA that encode the variable domain of the first species are mutated to create a framework derived from a second different mammalian species. Additionally, the constant domains of the antibody chain, if present, are also derived from the second mammalian species. This innovative approach has the potential to enhance the efficacy of antibody-based therapies.

Career Highlights

Throughout his career, Cobbold has worked with prominent companies in the biotechnology sector. Notable among these are BTG International Limited and Glaxo Wellcome Inc. His experience in these organizations has contributed to his expertise in antibody development and related technologies.

Collaborations

Cobbold has collaborated with several professionals in his field, including Scott David Gorman and Michael Ronald Clark. These collaborations have likely enriched his research and development efforts, leading to advancements in his patented technologies.

Conclusion

Stephen Paul Cobbold's contributions to the field of biotechnology through his patents on altered antibodies demonstrate his innovative spirit and commitment to advancing medical science. His work continues to influence the development of new therapeutic strategies.